TherapeuticsMD, Inc.
TXMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000025743
No open-market purchases or sales by TherapeuticsMD, Inc. insiders were filed in the last 90 days; 44 institutions reported holding it in 13F filings for Q2 2026, worth $9.10M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by TherapeuticsMD, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for TherapeuticsMD, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Thompson Tommy G | Director | 23,179 | Dec 29, 2025 | 2 |
| Naughton Gail K | Director | 8,500 | Nov 5, 2025 | 1 |
| Collins Cooper C. | Director | 60,516 | Nov 5, 2025 | 1 |
| Walker Marlan D | Chief Executive Officer | 73,639 | Nov 5, 2025 | 1 |
| Rubric Capital Management LP | Director, 10% Owner, Other: See Remarks. | 2,946,908Indirect | Nov 17, 2023 | 0 |
| Rosen David Efraim | 10% Owner | 2,946,908Indirect | Nov 17, 2023 | 0 |
| Ziegler Joseph | Principal Financial Officer | 7,500 | Aug 21, 2023 | 0 |
| Donegan Michael C | Prin. Fin. and Acctg. Officer | 61,853 | Apr 14, 2023 | 0 |
| Glickman Mark A | Co-Chief Executive Officer | 1,294 | Dec 9, 2022 | 0 |
| Bernick Brian | Co-Chief Executive Officer | 3,872 | Dec 9, 2022 | 0 |
| Bisaro Paul | Director | 5,922 | Oct 3, 2022 | 0 |
| Musing Jules A. | Director | 4,022 | Oct 3, 2022 | 0 |
| Russell Angus C. | Director | 5,792 | Oct 3, 2022 | 0 |
| Ling Karen | Director | 4,591 | Oct 3, 2022 | 0 |
| O'Dowd Hugh | Chief Executive Officer | – | Mar 31, 2022 | 0 |
| Carroll J Martin | Director | 106,864 | Aug 12, 2021 | 0 |
| DArecca James | Chief Financial Officer | 123,830 | Aug 12, 2021 | 0 |
| Borkowski Edward | EVP, Operations | – | Jul 2, 2021 | 0 |
| Finizio Robert G | CEO | – | Jul 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2025 (view filing) | Dec 23 | 6 days | Thompson Tommy GDirector | PPurchase | +8.40K | $1.67 | +$14.0K | +56.8%23.2K after | |
| Apr 15, 2025 (view filing) | Apr 14 | 1 day | Thompson Tommy GDirector | PPurchase | +325 | $1.00 | +$325 | +2.2%14.8K after | |
| Apr 15, 2025 (view filing) | Apr 14 | 1 day | Walker Marlan DChief Executive Officer | PPurchase | +490 | $1.00 | +$490 | +0.7%73.6K after | |
| Apr 10, 2025 (view filing) | Apr 9-10 | 1 day | Walker Marlan DChief Executive Officer | PPurchase | +2.30K | $0.8649 | +$1.99K | +3.3%73.1K after | 2 lots |
| Aug 26, 2024 (view filing) | Aug 22 | 4 days | Collins Cooper C.Director | PPurchase | +4.09K | $1.73 | +$7.08K | +8.5%52.0K after | |
| Aug 23, 2024 (view filing) | Aug 21 | 2 days | Collins Cooper C.Director | PPurchase | +1.20K | $1.70 | +$2.04K | +2.6%47.9K after | |
| Dec 7, 2023 (view filing) | Dec 6-7 | 1 day | Walker Marlan DChief Executive Officer | SSale | −19.1K | $2.29 | −$43.7K | −23.3%62.6K after | 2 lots |
| May 4, 2023 (view filing) | Apr 26 | 8 days | Walker Marlan DChief Executive Officer | SSale | −692 | $3.64 | −$2.52K | −5.6%11.6K after | Amended |
| Apr 14, 2023 (view filing) | Apr 12 | 2 days | Walker Marlan DChief Executive Officer | SSale | −1.17K | $3.65 | −$4.27K | −8.7%12.3K after | Amended |
| Jan 30, 2023 (view filing) | Jan 26-27 | 4 days | Donegan Michael CPrin. Fin. and Acctg. Officer | SSale | −1.70K | $5.08 | −$8.62K | −12.5%11.9K after | 2 lots |
| Jan 25, 2023 (view filing) | Jan 23-24 | 2 days | Donegan Michael CPrin. Fin. and Acctg. Officer | SSale | −1.31K | $5.34 | −$6.99K | −14.7%7.61K after | 2 lots |
| Dec 12, 2022 (view filing)11:14 AM ET | Dec 9 | 3 days | Rubric Capital Management LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.001 per share ("Common Stock") | +14.8K | $6.09 | +$90.3K | +0.9%1.76M after | |
| Dec 9, 2022 (view filing)10:58 AM ET | Dec 7 | 2 days | Rubric Capital Management LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.001 per share ("Common Stock") | +20.1K | $5.66 | +$113.9K | +1.2%1.74M after | |
| Dec 9, 2022 (view filing)10:58 AM ET | Dec 8 | 1 day | Rubric Capital Management LP and 1 other10% Owner | PPurchase | +300 | $5.83 | +$1.75K | 0.0%1.74M after | |
| Dec 9, 2022 (view filing) | Dec 6-9 | 3 daysLate | Bernick BrianCo-Chief Executive Officer | SSale | −1.25K | $5.27 | −$6.62K | −24.5%3.87K after | 2 lots |
| Dec 9, 2022 (view filing) | Dec 6 | 3 daysLate | Walker Marlan DGeneral Counsel | SSale | −1.05K | $4.95 | −$5.19K | −13.6%6.68K after | |
| Dec 9, 2022 (view filing) | Dec 6 | 3 daysLate | Glickman Mark ACo-Chief Executive Officer | SSale | −440 | $4.92 | −$2.16K | −25.4%1.29K after | |
| Dec 9, 2022 (view filing) | Dec 6 | 3 daysLate | Donegan Michael CInterim CFO/CAO/VP of Finance | SSale | −910 | $4.78 | −$4.35K | −16.7%4.55K after | |
| Dec 8, 2022 (view filing) | Dec 7 | 1 day | Naughton Gail KDirector | SSale | −3.92K | $5.26 | −$20.6K | −100.0%0 after | |
| Oct 31, 2022 (view filing)12:12 PM ET | Oct 28 | 3 days | Rubric Capital Management LP and 1 other10% Owner | PPurchaseSeries A Preferred Stock, par value $0.001 per share | +7.00K | $1,000.00 | +$7.00M | +31.8%29.0K after | |
| Oct 3, 2022 (view filing)5:40 PM ET | Sep 30 | 3 days | Rubric Capital Management LP and 1 other10% Owner | PPurchaseSeries A Preferred Stock, par value $0.001 per share | +7.00K | $1,000.00 | +$7.00M | +46.7%22.0K after | |
| Aug 1, 2022 (view filing)6:11 PM ET | Jul 29 | 3 days | Rubric Capital Management LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.001 per share ("Common Stock") | +565.0K | $4.72 | +$2.67M | +48.8%1.72M after | |
| Aug 1, 2022 (view filing)6:11 PM ET | Jul 29 | 3 days | Rubric Capital Management LP and 1 other10% Owner | PPurchaseSeries A Preferred Stock, par value $0.001 per share | +15.0K | $822.21 | +$12.3M | New position15.0K after | |
| Jul 19, 2022 (view filing)11:28 AM ET | Jul 15 | 4 days | Rubric Capital Management LP and 1 other10% Owner | PPurchaseCommon Stock, par value $0.001 per share ("Common Stock") | +64.9K | $5.56 | +$360.8K | +6.0%1.14M after | |
| Jul 19, 2022 (view filing)11:28 AM ET | Jul 18 | 1 day | Rubric Capital Management LP and 1 other10% Owner | PPurchase | +17.7K | $6.03 | +$106.7K | +1.6%1.16M after | |
| Dec 2, 2021 (view filing) | Nov 30 | 2 days | Donegan Michael CCAO and VP of Finance | SSale | −29.8K | $0.54 | −$16.1K | −23.1%99.4K after | |
| Nov 22, 2021 (view filing) | Nov 18 | 4 days | Collins Cooper C.Director | PPurchase | +1.00M | $0.58 | +$580.0K | +80.8%2.24M after | |
| Aug 19, 2021 (view filing) | Aug 17 | 2 days | Ling KarenDirector | PPurchase | +33.4K | $0.75 | +$25.1K | +34.5%130.3K after | |
| Aug 19, 2021 (view filing) | Aug 17-18 | 2 days | Collins Cooper C.Director | PPurchase | +1.00M | $0.725 | +$725.0K | +422.2%1.24M after | 2 lots |
| Aug 18, 2021 (view filing) | Aug 16 | 2 days | Bisaro PaulDirector | PPurchase | +50.0K | $0.79 | +$39.5K | +34.0%196.9K after | |
| Aug 17, 2021 (view filing) | Aug 13 | 4 days | Thompson Tommy GDirector | PPurchase | +11.0K | $0.87 | +$9.57K | +1.6%715.6K after | |
| Aug 12, 2021 (view filing) | Aug 12 | Same day | DArecca JamesChief Financial Officer | SSale | −93.3K | $0.87 | −$81.2K | −43.0%123.8K after |